10-KPeriod: FY1994

CARDINAL HEALTH INC Annual Report, Year Ended Jun 30, 1994

Filed September 2, 1994For Securities:CAH

Summary

This 10-K filing from Cardinal Health Inc. for the period ending June 29, 1994, represents a snapshot of the company's financial performance and strategic positioning in the healthcare distribution sector. As a relatively early-stage filing for a company that has since grown significantly, it provides insight into the foundational elements of its business. Investors in this period would have been focused on the company's revenue growth, profitability, and its market share within the essential healthcare supply chain.

Key Highlights

  • 1Cardinal Health Inc. operates within the healthcare services sector, focusing on the distribution of pharmaceuticals and medical products.
  • 2The filing covers the fiscal year ending June 29, 1994, providing historical financial data for analysis.
  • 3The company's business model relies on efficient logistics and supply chain management to serve healthcare providers.
  • 4Key financial metrics to be scrutinized from the full report (not provided here) would include revenue, cost of goods sold, operating expenses, and net income.
  • 5Understanding the competitive landscape and Cardinal Health's market penetration is crucial for assessing its growth potential.
  • 6The filing would detail the company's assets, liabilities, and equity, offering a view of its financial structure and solvency.

Frequently Asked Questions

As of the 1994 fiscal year-end, Cardinal Health Inc. was primarily engaged in the distribution of pharmaceuticals and medical products to healthcare providers, playing a critical role in the healthcare supply chain.

Investors would have focused on revenue growth, gross profit margins, operating income, net earnings, and the company's balance sheet strength, including its asset base and debt levels, to gauge its financial health and growth trajectory.

This 1994 filing provides historical context for Cardinal Health's early development. It allows for an analysis of the company's foundational business strategy and its performance in its formative years, which can be compared against its current large-scale operations.

Potential risks in 1994 would have included intense competition in the distribution market, regulatory changes affecting the healthcare industry, potential supply chain disruptions, and the ability to manage inventory and logistics efficiently to maintain profitability.